{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:38:50Z","timestamp":1791221930265,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2840-13-76","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T23:01:59Z","timestamp":1397084519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs"],"prefix":"10.1186","volume":"13","author":[{"given":"Mohamed","family":"Abu-Farha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Behbehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Elkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"issue":"1","key":"826_CR1","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, et al: Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association. Circulation. 2013, 127 (1): e6-e245. 10.1161\/CIR.0b013e31828124ad.","journal-title":"Circulation"},{"issue":"1","key":"826_CR2","doi-asserted-by":"publisher","first-page":"T17","DOI":"10.1530\/JOE-12-0232","volume":"216","author":"HS Mattu","year":"2013","unstructured":"Mattu HS, Randeva HS: Role of adipokines in cardiovascular disease. J Endocrinol. 2013, 216 (1): T17-T36. 10.1530\/JOE-12-0232.","journal-title":"J Endocrinol"},{"issue":"14","key":"826_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ: The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010, 56 (14): 1113-1132. 10.1016\/j.jacc.2010.05.034.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"826_CR4","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/archinte.165.21.2479","volume":"165","author":"CM Ballantyne","year":"2005","unstructured":"Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E: Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2005, 165 (21): 2479-2484. 10.1001\/archinte.165.21.2479.","journal-title":"Arch Intern Med"},{"issue":"20","key":"826_CR5","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","volume":"279","author":"JR Downs","year":"1998","unstructured":"Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998, 279 (20): 1615-1622. 10.1001\/jama.279.20.1615.","journal-title":"JAMA"},{"issue":"9491","key":"826_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J: The metabolic syndrome\u2013a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016\/S0140-6736(05)67402-8.","journal-title":"Lancet"},{"issue":"7","key":"826_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.metabol.2004.02.004","volume":"53","author":"JS Yudkin","year":"2004","unstructured":"Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A: Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004, 53 (7): 852-857. 10.1016\/j.metabol.2004.02.004.","journal-title":"Metabolism"},{"issue":"9","key":"826_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","volume":"54","author":"SE Wozniak","year":"2009","unstructured":"Wozniak SE, Gee LL, Wachtel MS, Frezza EE: Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009, 54 (9): 1847-1856. 10.1007\/s10620-008-0585-3.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"826_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1160\/TH13-03-0212","volume":"110","author":"G Rega-Kaun","year":"2013","unstructured":"Rega-Kaun G, Kaun C, Wojta J: More than a simple storage organ: Adipose tissue as a source of adipokines involved in cardiovascular disease. Thromb Haemost. 2013, 110 (4): 641-650. 10.1160\/TH13-03-0212.","journal-title":"Thromb Haemost"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"513948","DOI":"10.1155\/2010\/513948","volume":"2010","author":"JN Fain","year":"2010","unstructured":"Fain JN: Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm. 2010, 2010: 513948.","journal-title":"Mediators Inflamm"},{"issue":"1\u20132","key":"826_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K: Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007, 380 (1\u20132): 24-30.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"826_CR12","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","volume":"26","author":"MC Alessi","year":"2006","unstructured":"Alessi MC, Juhan-Vague I: PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006, 26 (10): 2200-2207. 10.1161\/01.ATV.0000242905.41404.68.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"826_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6823-11-13","volume":"11","author":"RI Pereira","year":"2011","unstructured":"Pereira RI, Wang CC, Hosokawa P, Dickinson LM, Chonchol M, Krantz MJ, Steiner JF, Bessesen DH, Havranek EP, Long CS: Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord. 2011, 11: 13-10.1186\/1472-6823-11-13.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"826_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","volume":"61","author":"UI Khan","year":"2012","unstructured":"Khan UI, Wang D, Sowers MR, Mancuso P, Everson-Rose SA, Scherer PE, Wildman RP: Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism. 2012, 61 (9): 1261-1269. 10.1016\/j.metabol.2012.02.005.","journal-title":"Metabolism"},{"issue":"3","key":"826_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5812\/ijem.8298","volume":"11","author":"KH Chin","year":"2013","unstructured":"Chin KH, Sathyasurya DR, Abu Saad H, Jan Mohamed HJ: Effect of ethnicity, dietary intake and physical activity on plasma adiponectin concentrations among malaysian patients with type 2 diabetes mellitus. Int J Endocrinol Metab. 2013, 11 (3): 167-174.","journal-title":"Int J Endocrinol Metab"},{"key":"826_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1475-2840-12-170","volume":"12","author":"DC Sulistyoningrum","year":"2013","unstructured":"Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM: Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013, 12: 170-10.1186\/1475-2840-12-170.","journal-title":"Cardiovasc Diabetol"},{"key":"826_CR17","volume-title":"Int J Obes (Lond)","author":"Y Morimoto","year":"2014","unstructured":"Morimoto Y, Conroy SM, Ollberding NJ, Kim Y, Lim U, Cooney RV, Franke AA, Wilkens LR, Hernandez BY, Goodman MT, Henderson BE, Kolonel LN, Le Marchand L, Maskarinec G: Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes (Lond). 2014, doi:10.1038\/ijo.2014.25"},{"issue":"5","key":"826_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2105\/AJPH.2011.300290","volume":"102","author":"C Hajat","year":"2012","unstructured":"Hajat C, Harrison O, Al Siksek Z: Weqaya: a population-wide cardiovascular screening program in Abu Dhabi, United Arab Emirates. Am J Public Health. 2012, 102 (5): 909-914. 10.2105\/AJPH.2011.300290.","journal-title":"Am J Public Health"},{"issue":"16","key":"826_CR19","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"key":"826_CR20","volume-title":"Eur J Prev Cardiol","author":"M Santaniemi","year":"2013","unstructured":"Santaniemi M, Ukkola O, Malo E, Bloigu R, Kesaniemi YA: Metabolic syndrome in the prediction of cardiovascular events: The potential additive role of hsCRP and adiponectin. Eur J Prev Cardiol. 2013, doi:10.1177\/2047487313494028"},{"key":"826_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2840-7-35","volume":"7","author":"ES Ford","year":"2008","unstructured":"Ford ES, Schulze MB, Pischon T, Bergmann MM, Joost HG, Boeing H: Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovasc Diabetol. 2008, 7: 35-10.1186\/1475-2840-7-35.","journal-title":"Cardiovasc Diabetol"},{"key":"826_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1475-2840-7-27","volume":"7","author":"C Kelliny","year":"2008","unstructured":"Kelliny C, William J, Riesen W, Paccaud F, Bovet P: Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008, 7: 27-10.1186\/1475-2840-7-27.","journal-title":"Cardiovasc Diabetol"},{"key":"826_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1475-2840-11-40","volume":"11","author":"FH Chiu","year":"2012","unstructured":"Chiu FH, Chuang CH, Li WC, Weng YM, Fann WC, Lo HY, Sun C, Wang SH: The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol. 2012, 11: 40-10.1186\/1475-2840-11-40.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"826_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1177\/147323001003800605","volume":"38","author":"B Lu","year":"2010","unstructured":"Lu B, Zhang S, Wen J, Yang Y, Yang Z, Zhang Z, Wang X, Hu R: The New Unified International Diabetes Federation\/American Heart Association\/National Heart, Lung, and Blood Institute Metabolic Syndrome definition: does it correlate better with C-reactive protein in Chinese patients diagnosed with type 2 diabetes?. J Int Med Res. 2010, 38 (6): 1923-1932. 10.1177\/147323001003800605.","journal-title":"J Int Med Res"},{"issue":"1","key":"826_CR25","doi-asserted-by":"publisher","first-page":"e54615","DOI":"10.1371\/journal.pone.0054615","volume":"8","author":"H Zuo","year":"2013","unstructured":"Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A: Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One. 2013, 8 (1): e54615-10.1371\/journal.pone.0054615.","journal-title":"PLoS One"},{"issue":"1","key":"826_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1748-1716.2010.02237.x","volume":"203","author":"MR Meyer","year":"2011","unstructured":"Meyer MR, Clegg DJ, Prossnitz ER, Barton M: Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011, 203 (1): 259-269. 10.1111\/j.1748-1716.2010.02237.x.","journal-title":"Acta Physiol (Oxf)"},{"issue":"9","key":"826_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/138945007781662337","volume":"8","author":"JM Cale","year":"2007","unstructured":"Cale JM, Lawrence DA: Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent. Curr Drug Targets. 2007, 8 (9): 971-981. 10.2174\/138945007781662337.","journal-title":"Curr Drug Targets"},{"issue":"8549","key":"826_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","volume":"2","author":"A Hamsten","year":"1987","unstructured":"Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987, 2 (8549): 3-9.","journal-title":"Lancet"},{"issue":"9","key":"826_CR29","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1161\/01.CIR.94.9.2057","volume":"94","author":"I Juhan-Vague","year":"1996","unstructured":"Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996, 94 (9): 2057-2063. 10.1161\/01.CIR.94.9.2057.","journal-title":"Circulation"},{"issue":"2","key":"826_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0021-9150(03)00095-9","volume":"168","author":"A Panahloo","year":"2003","unstructured":"Panahloo A, Mohamed-Ali V, Gray RP, Humphries SE, Yudkin JS: Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G\/5G) polymorphism in the PAI-1 gene. Atherosclerosis. 2003, 168 (2): 297-304. 10.1016\/S0021-9150(03)00095-9.","journal-title":"Atherosclerosis"},{"issue":"24","key":"826_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJM200006153422419","volume":"342","author":"HP Kohler","year":"2000","unstructured":"Kohler HP, Grant PJ: Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 2000, 342 (24): 1792-1801. 10.1056\/NEJM200006153422406.","journal-title":"N Engl J Med"},{"issue":"3","key":"826_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/01.ATV.19.3.562","volume":"19","author":"A Festa","year":"1999","unstructured":"Festa A, D'Agostino R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999, 19 (3): 562-568. 10.1161\/01.ATV.19.3.562.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3 Pt 2","key":"826_CR33","first-page":"331","volume":"13","author":"I Juhan-Vague","year":"1987","unstructured":"Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C: Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabete Metab. 1987, 13 (3 Pt 2): 331-336.","journal-title":"Diabete Metab"},{"issue":"Suppl 2","key":"826_CR34","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0167-4943(09)70012-3","volume":"49","author":"YY Chou","year":"2009","unstructured":"Chou YY, Sheu WH, Tang YJ, Chen YM, Liao SC, Chuang YW, Lin CS, Chen DY: Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan. Arch Gerontol Geriatr. 2009, 49 (Suppl 2): S41-S45.","journal-title":"Arch Gerontol Geriatr"},{"issue":"12","key":"826_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.metabol.2006.08.005","volume":"55","author":"N Hashimoto","year":"2006","unstructured":"Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, Hashimoto T, Sato K, Kushida S, Suzuki M, Yano S, Iwai R, Takahashi H, Yoshida S: Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism. 2006, 55 (12): 1653-1657. 10.1016\/j.metabol.2006.08.005.","journal-title":"Metabolism"},{"issue":"1","key":"826_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","volume":"23","author":"M Kumada","year":"2003","unstructured":"Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003, 23 (1): 85-89. 10.1161\/01.ATV.0000048856.22331.50.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"826_CR37","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/01.HYP.0000222368.43759.a1","volume":"47","author":"K Ohashi","year":"2006","unstructured":"Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006, 47 (6): 1108-1116. 10.1161\/01.HYP.0000222368.43759.a1.","journal-title":"Hypertension"},{"issue":"14","key":"826_CR38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","volume":"291","author":"T Pischon","year":"2004","unstructured":"Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004, 291 (14): 1730-1737. 10.1001\/jama.291.14.1730.","journal-title":"JAMA"},{"issue":"1","key":"826_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1559-4572.2008.00030.x","volume":"4","author":"J Kawano","year":"2009","unstructured":"Kawano J, Arora R: The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr. 2009, 4 (1): 44-49. 10.1111\/j.1559-4572.2008.00030.x.","journal-title":"J Cardiometab Syndr"},{"issue":"3","key":"826_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11892-003-0065-2","volume":"3","author":"UB Pajvani","year":"2003","unstructured":"Pajvani UB, Scherer PE: Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep. 2003, 3 (3): 207-213. 10.1007\/s11892-003-0065-2.","journal-title":"Curr Diab Rep"},{"issue":"2","key":"826_CR41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2337\/diabetes.51.2.536","volume":"51","author":"K Hara","year":"2002","unstructured":"Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002, 51 (2): 536-540. 10.2337\/diabetes.51.2.536.","journal-title":"Diabetes"},{"issue":"1\u20132","key":"826_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cca.2007.06.006","volume":"384","author":"K Kotani","year":"2007","unstructured":"Kotani K, Saiga K, Kurozawa Y, Sakane N, Tsuzaki K, Hamada T: Adiponectin I164T gene polymorphism and the obesity-related effects on the Japanese female population. Clin Chim Acta. 2007, 384 (1\u20132): 182-183.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"826_CR43","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1210\/jc.2005-0293","volume":"90","author":"C Pagano","year":"2005","unstructured":"Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E, Andrighetto G, Federspil G, Vettor R: Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab. 2005, 90 (7): 4335-4340. 10.1210\/jc.2005-0293.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"826_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1507\/endocrj.52.519","volume":"52","author":"CC Zou","year":"2005","unstructured":"Zou CC, Liang L, Hong F, Fu JF, Zhao ZY: Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J. 2005, 52 (5): 519-524. 10.1507\/endocrj.52.519.","journal-title":"Endocr J"},{"issue":"1","key":"826_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1475-2840-12-119","volume":"12","author":"P Saddi-Rosa","year":"2013","unstructured":"Saddi-Rosa P, de Oliveira CS V, Crispim F, Giuffrida FM, de Lima VC, Vieira JG, Doria A, Velho G, Reis AF: Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT\/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovasc Diabetol. 2013, 12 (1): 119-10.1186\/1475-2840-12-119.","journal-title":"Cardiovasc Diabetol"},{"key":"826_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1475-2840-7-8","volume":"7","author":"JG Maresh","year":"2008","unstructured":"Maresh JG, Shohet RV: In vivo endothelial gene regulation in diabetes. Cardiovasc Diabetol. 2008, 7: 8-10.1186\/1475-2840-7-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"826_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1540\/jsmr.48.27","volume":"48","author":"SE Lee","year":"2012","unstructured":"Lee SE, Kim HS: Human resistin in cardiovascular disease. J Smooth Muscle Res. 2012, 48 (1): 27-35. 10.1540\/jsmr.48.27.","journal-title":"J Smooth Muscle Res"},{"issue":"1","key":"826_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2840-10-13","volume":"10","author":"J Westerink","year":"2011","unstructured":"Westerink J, Visseren FL: Pharmacological and non-pharmacological interventions to influence adipose tissue function. Cardiovasc Diabetol. 2011, 10 (1): 13-10.1186\/1475-2840-10-13.","journal-title":"Cardiovasc Diabetol"},{"key":"826_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1475-2840-11-132","volume":"11","author":"AE Mirrakhimov","year":"2012","unstructured":"Mirrakhimov AE: Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol. 2012, 11: 132-10.1186\/1475-2840-11-132.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"826_CR50","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.2337\/dc09-1392","volume":"33","author":"A Mente","year":"2010","unstructured":"Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, Teo K, Gerstein H, Sharma AM, Yusuf S, Anand SS: Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010, 33 (7): 1629-1634. 10.2337\/dc09-1392.","journal-title":"Diabetes Care"},{"issue":"2","key":"826_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2337\/dc06-1073","volume":"30","author":"JV Silha","year":"2007","unstructured":"Silha JV, Nyomba BL, Leslie WD, Murphy LJ: Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care. 2007, 30 (2): 286-291. 10.2337\/dc06-1073.","journal-title":"Diabetes Care"},{"issue":"1","key":"826_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2003.07.002","volume":"53","author":"MW Hulver","year":"2004","unstructured":"Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA: Ethnic differences in adiponectin levels. Metabolism. 2004, 53 (1): 1-3. 10.1016\/j.metabol.2003.07.002.","journal-title":"Metabolism"},{"issue":"1","key":"826_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1089\/met.2012.0065","volume":"11","author":"H Gardener","year":"2013","unstructured":"Gardener H, Crisby M, Sjoberg C, Hudson B, Goldberg R, Mendez AJ, Wright CB, Rundek T, Elkind MS, Sacco RL: Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metab Syndr Relat Disord. 2013, 11 (1): 46-55. 10.1089\/met.2012.0065.","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"826_CR54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.gene.2013.06.057","volume":"527","author":"F Zadjali","year":"2013","unstructured":"Zadjali F, Al-Yahyaee S, Hassan MO, Albarwani S, Bayoumi RA: Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: family-based study. Gene. 2013, 527 (2): 663-669. 10.1016\/j.gene.2013.06.057.","journal-title":"Gene"},{"issue":"1","key":"826_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.gene.2011.11.045","volume":"493","author":"NM Al-Daghri","year":"2012","unstructured":"Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Hussain T, Yakout S, Vinodson B, Sabico S: Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene. 2012, 493 (1): 142-147. 10.1016\/j.gene.2011.11.045.","journal-title":"Gene"},{"issue":"2","key":"826_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.diabres.2012.02.015","volume":"97","author":"N Mtiraoui","year":"2012","unstructured":"Mtiraoui N, Ezzidi I, Turki A, Chaieb A, Mahjoub T, Almawi WY: Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract. 2012, 97 (2): 290-297. 10.1016\/j.diabres.2012.02.015.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"826_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0003319712455497","volume":"64","author":"NM Rizk","year":"2013","unstructured":"Rizk NM, El-Menyar A, Marei I, Sameer M, Musad T, Younis D, Farag F, Basem N, Al-Ali K, Al Suwaidi J: Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 2013, 64 (4): 257-265. 10.1177\/0003319712455497.","journal-title":"Angiology"},{"key":"826_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2840-12-7","volume":"12","author":"M Juanola-Falgarona","year":"2013","unstructured":"Juanola-Falgarona M, Salas-Salvado J, Estruch R, Portillo MP, Casas R, Miranda J, Martinez-Gonzalez MA, Bullo M: Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc Diabetol. 2013, 12: 7-10.1186\/1475-2840-12-7.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-13-76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:31:24Z","timestamp":1630553484000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-13-76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-13-76","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]},"assertion":[{"value":"17 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}